Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY. Wijmenga-Monsuur AJ, et al. Among authors: goldblatt d. PLoS One. 2016 May 11;11(5):e0155088. doi: 10.1371/journal.pone.0155088. eCollection 2016. PLoS One. 2016. PMID: 27168324 Free PMC article.
Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY. Wijmenga-Monsuur AJ, et al. Among authors: goldblatt d. PLoS One. 2015 Dec 10;10(12):e0144739. doi: 10.1371/journal.pone.0144739. eCollection 2015. PLoS One. 2015. PMID: 26658902 Free PMC article. Clinical Trial.
Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster dose.
van Westen E, Rodenburg GD, van Gils EJ, Tcherniaeva I, Berbers GA, Cowell L, Goldblatt D, Rots NY, van den Dobbelsteen GP, Sanders EA. van Westen E, et al. Among authors: goldblatt d. Vaccine. 2013 Dec 2;31(49):5834-42. doi: 10.1016/j.vaccine.2013.09.073. Epub 2013 Oct 10. Vaccine. 2013. PMID: 24120678 Free article. Clinical Trial.
Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes.
Grant LR, O'Brien SE, Burbidge P, Haston M, Zancolli M, Cowell L, Johnson M, Weatherholtz RC, Reid R, Santosham M, O'Brien KL, Goldblatt D. Grant LR, et al. Among authors: goldblatt d. PLoS One. 2013 Sep 23;8(9):e74906. doi: 10.1371/journal.pone.0074906. eCollection 2013. PLoS One. 2013. PMID: 24086394 Free PMC article.
Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial.
Kandasamy R, Gurung M, Thorson S, Yu LM, Galal U, Voysey M, Kelly S, Wahl B, Berbers G, Finnegan K, Ansari I, Paudel K, Murdoch DR, O'Brien KL, Kelly DF, Goldblatt D, Shrestha S, Pollard AJ. Kandasamy R, et al. Among authors: goldblatt d. Lancet Infect Dis. 2019 Feb;19(2):156-164. doi: 10.1016/S1473-3099(18)30568-1. Epub 2019 Jan 8. Lancet Infect Dis. 2019. PMID: 30635252 Clinical Trial.
Natural IgM antibodies in the immune defence against neoehrlichiosis.
Wennerås C, Goldblatt D, Zancolli M, Mattsson M, Wass L, Hörkkö S, Rosén A. Wennerås C, et al. Among authors: goldblatt d. Infect Dis (Lond). 2017 Nov-Dec;49(11-12):809-816. doi: 10.1080/23744235.2017.1347815. Epub 2017 Jul 6. Infect Dis (Lond). 2017. PMID: 28682152
437 results